GB Sciences, Inc. (GBLX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Sep 23, 16:00
GB Sciences Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2024 | -0.5064M |
| September 30, 2024 | -0.5875M |
| June 30, 2024 | -0.8924M |
| March 31, 2024 | -0.9757M |
| December 31, 2023 | -0.9431M |
| September 30, 2023 | -1.137M |
| June 30, 2023 | -1.340M |
| March 31, 2023 | -1.527M |
| December 31, 2022 | -1.972M |
| September 30, 2022 | -2.001M |
| June 30, 2022 | -1.522M |
| March 31, 2022 | -1.866M |
| December 31, 2021 | -2.133M |
| September 30, 2021 | -2.745M |
| June 30, 2021 | -2.498M |
| March 31, 2021 | -2.185M |
| December 31, 2020 | -1.485M |
| September 30, 2020 | -2.904M |
| June 30, 2020 | -2.172M |
| March 31, 2020 | -4.480M |
| December 31, 2019 | -6.256M |
| September 30, 2019 | -5.260M |
| June 30, 2019 | -8.991M |
| March 31, 2019 | -9.856M |
| December 31, 2018 | -12.07M |
| Date | Value |
|---|---|
| September 30, 2018 | -13.38M |
| June 30, 2018 | -13.55M |
| March 31, 2018 | -12.25M |
| December 31, 2017 | -9.650M |
| September 30, 2017 | -8.027M |
| June 30, 2017 | -5.701M |
| March 31, 2017 | -4.469M |
| December 31, 2016 | -3.543M |
| September 30, 2016 | -3.692M |
| June 30, 2016 | -3.435M |
| March 31, 2016 | -3.564M |
| December 31, 2015 | -3.093M |
| September 30, 2015 | -2.666M |
| June 30, 2015 | -3.694M |
| March 31, 2015 | -3.546M |
| December 31, 2014 | -3.495M |
| September 30, 2014 | -2.631M |
| June 30, 2014 | -1.142M |
| March 31, 2014 | -0.2136M |
| December 31, 2013 | -0.0344M |
| September 30, 2013 | -0.0407M |
| June 30, 2013 | -0.0462M |
| March 31, 2013 | -0.0374M |
| December 31, 2012 | -0.0452M |
| September 30, 2012 | -0.0428M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Cocrystal Pharma, Inc. | -8.263M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | -207.00M |
| Fulcrum Therapeutics, Inc. | -65.78M |
| Definium Therapeutics, Inc. | -166.74M |